Besch Doug 4
4 · OptimizeRx Corp · Filed Feb 21, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Besch Doug
Chief Product Officer
Transactions
- Award
Stock Option
2023-12-19+5,892→ 5,892 totalExercise: $12.73Exp: 2026-12-19→ Common Stock (5,892 underlying) - Award
Restricted Stock Units
2023-12-19+5,892→ 5,892 totalExp: 2026-12-19→ Common Stock (5,892 underlying)
Footnotes (3)
- [F1]The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.